p300 modulates the BRCA1 inhibition of estrogen receptor activity

Cancer Research

Volumn 62, Issue 1, 2002, Pages 141-151

  Fan, Saijun ^a   Ma, Yong Xian ^a   Yuan, Ren Qi ^a   Meng, Qinghui ^a   Wang, Ji An ^a   Goldberg, Itzhak D ^a   Rosen, Eliot M ^a   Wang, Chenguang ^b   Pestell, Richard G ^b   Erdos, Michael ^c   Webb, Paul ^d   Kushner, Peter J ^d  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GENE PRODUCT; GLUCOCORTICOID RECEPTOR; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN P300; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER SUSCEPTIBILITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER;

BRCA1 PROTEIN; BREAST NEOPLASMS; CREB-BINDING PROTEIN; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; GENES, BRCA1; HUMANS; MALE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0036141456     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
2. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
3. BRCA1 mutations in primary breast and ovarian carcinomas
4. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds
5. BRCA1 is a 200 kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner
6. WAF1/C1P1
7. Induction of apoptosis by tumor suppressor protein BRCA1
8. BRCA1 as a human prostate tumor suppressor: Modulation of proliferation, damage responses, and expression of regulatory proteins
9. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
10. BRCA1 required for transcription-coupled repair of oxidative DNA damage
11. BRCAI controls homology-directed DNA repair
12. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
13. BRCA1 inhibits estrogen receptor signaling in transfected cells
14. Selective estrogen receptor modulators: Structure, function, and clinical use
15. Chemoprevention of breast cancer
16. Nuclear receptors in Sicily: All in the famiglia
17. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
18. AF-2 activity and recruitment of steroid receptor coactivator 1 to an estrogen receptor depend on a lysine residue conserved in nuclear receptors
19. Co-ordinate down-regulation of BRCA1, BRCA2, Rad51, and p300 during the response to damage in human prostate cancer cell lines
20. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents
21. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
22. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein
23. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
24. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
25. WAF1/C1P1 protein in human carcinoma cell lines
26. p300 is a component of an estrogen receptor coactivator complex
27. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid dependent transcription
28. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
29. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation
30. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators
31. Histone acetyl transferase activity is conserved between yeast and human GCN5, and is required for complementation of growth and transcriptional activation
32. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GR1P1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
33. Nuclear receptor ligands and ligand-binding domains
34. Transcriptional activation by estrogen receptors
35. Role of CBP/p300 in nuclear receptor signalling
36. Nuclear integration of JAK/STAT and Ras/AP-1 signalling by CBP and p300
37. The CBP co-activator is a histone acetyl transferase
38. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300
39. CBP/p300 interact with and function as transcriptional coactivators of BRCA1
40. BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodelling to breast cancer
41. BRCA1 interacts with components of the histone deacetylase complex
42. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression
43. BRCAI is a component of the RNA polymerase II holoenzyme
44. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families